Juno Therapeutics, one of the most closely watched biotechs in the hot CAR-T space, turned up at ASCO on Monday to tell the industry that it has made some significant upgrades to its therapeutic design that should help it move closer to commercialization with a product that can be efficiently manufactured by the fast-growing company.

…read more

Source: Juno amps up its CAR-T tech in drive toward a pivotal test


0 No comments